Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-01 Sale | 2026-07-06 3:37 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,698 | $33.13 | $155,645 | 100,991 (Direct) | View |
| 2026-06-15 Sale | 2026-06-15 6:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 2,000 | $25.05 | $50,100 | 21,095 (Direct) | View |
| 2026-06-15 Sale | 2026-06-15 6:46 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 1,899 | $24.62 | $46,753 | 94,462 (Direct) | View |
| 2026-06-01 Sale | 2026-06-01 7:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,653 | $23.77 | $110,602 | 105,689 (Direct) | View |
| 2026-05-18 Sale | 2026-05-18 6:41 pm | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 5,740 | $25.12 | $144,189 | 42,009 (Direct) | View |
| 2026-05-05 Sale | 2026-05-06 2:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 344 | $24.96 | $8,586 | 111,189 (Direct) | View |
| 2026-05-01 Sale | 2026-05-04 5:35 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,683 | $24.9 | $116,607 | 110,342 (Direct) | View |
| 2026-04-01 Sale | 2026-04-02 6:19 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 4,683 | $20.97 | $98,203 | 80,351 (Direct) | View |
| 2026-03-06 Sale | 2026-03-10 4:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 9,526 | $21.87 | $208,312 | 66,820 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 7:09 pm | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 10,029 | $22.8 | $228,661 | 110,026 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 7:08 pm | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 10,539 | $22.8 | $240,289 | 89,515 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 7:06 pm | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 54,404 | $22.8 | $1,240,411 | 2,817,979 (Indirect Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 8,135 | $22.8 | $185,478 | 76,346 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:51 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 1,632 | $22.8 | $37,210 | 48,670 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 10,044 | $22.65 | $227,538 | 85,034 (Direct) | View |
| 2026-03-02 Sale | 2026-03-03 6:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 7,029 | $22.8 | $160,261 | 76,301 (Direct) | View |
| 2026-02-02 Sale | 2026-02-03 12:00 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,061 | $23.56 | $72,117 | 88,935 (Direct) | View |
| 2026-01-02 Sale | 2026-01-05 4:07 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,150 | $22.84 | $71,946 | 91,996 (Direct) | View |
| 2025-12-29 Sale | 2025-12-30 1:49 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 85 | $34.38 | $2,922 | 50,450 (Direct) | View |
| 2025-12-10 Sale | 2025-12-11 12:10 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 3,081 | $36.38 | $112,087 | 95,146 (Direct) | View |
| 2025-10-13 Sale | 2025-10-14 12:15 pm | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 7,942 | $31.51 | $250,252 | 98,227 (Direct) | View |
| 2025-09-18 Sale | 2025-09-19 6:23 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 64 | $29.17 | $1,867 | 50,242 (Direct) | View |
| 2025-09-12 Sale | 2025-09-12 4:11 pm | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 2,450 | $31.17 | $76,367 | 73,271 (Direct) | View |
| 2025-09-05 Sale | 2025-09-08 2:01 pm | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 84 | $31.39 | $2,637 | 50,306 (Direct) | View |
| 2025-06-20 Sale | 2025-06-23 1:50 pm | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 2,405 | $37.39 | $89,923 | 15,344 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-05-14 Option Award | 2026-05-18 6:50 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director | 21,809 | $0 | 47,754 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:41 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director | 21,809 | $0 | 42,009 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:39 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | Ray Amrit Director | 21,809 | $0 | 45,174 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:38 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | Sanders Corazon (Corsee) D. Director | 21,809 | $0 | 37,153 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:35 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director | 21,809 | $0 | 54,499 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:23 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director | 21,809 | $0 | 54,499 (Direct) | View |
| 2026-05-14 Option Award | 2026-05-18 6:21 pm | N/A 2036-05-14 | Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director | 21,809 | $0 | 52,624 (Direct) | View |
| 2026-04-22 Option Award | 2026-04-24 4:39 pm | N/A 2036-04-22 | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 27,589 | $0 | 76,259 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:19 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 209,438 | $0 | 3,027,417 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:17 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 103,052 | $0 | 227,781 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:16 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 103,052 | $0 | 213,078 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:15 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 78,855 | $0 | 145,675 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:13 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 78,855 | $0 | 168,370 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:11 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 94,626 | $0 | 170,927 (Direct) | View |
| 2026-04-16 Option Award | 2026-04-20 5:09 pm | N/A 2036-04-16 | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 94,626 | $0 | 174,977 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 7:09 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Pinion John Richard See Remarks | 11,137 | $0 | 110,026 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 7:08 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer | 11,643 | $0 | 89,515 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 7:06 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO | 71,177 | $0 | 2,817,979 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:51 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and Chief Legal Officer | 11,137 | $0 | 76,346 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:51 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Chief Accounting Officer | 148 | $23.39 | 48,670 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:50 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Horn Howard Chief Financial Officer | 6,143 | $0 | 85,034 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:49 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Crombez Eric EVP and Chief Medical Officer | 11,643 | $0 | 76,301 (Direct) | View |
| 2026-03-01 Option Award | 2026-03-03 6:49 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 11,137 | $0 | 124,729 (Direct) | View |
| 2026-03-02 Tax Withholding | 2026-03-03 6:49 pm | N/A N/A | Ultragenyx Pharmaceutical Inc. | RARE | Huang Dennis Karl See Remarks | 999 | $23.39 | 124,729 (Direct) | View |